SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Evaluating medicine prices, availability and affordability in Bangladesh using World Health Organisation and Health Action International methodology
9 references·1 citing·31 second hop
Evaluating medicine prices, availability and affordability in Bangladesh using World Health Organisation and Health Action International methodology (2019)Evaluating medicine prices, availability …Bangladesh policy on prevention and control of non-communicable diseases: a policy analysis (2017)Bangladesh policy on preventi…Bangladesh Health Facility Survey 2014 (2016)Bangladesh Health Facility Su…Global, regional, and national age–sex specifi c all-cause andcause-specifi c mortality for 240 causes of death, 1990–2013:a systematic analysis for the Global Burden of DiseaseStudy 2013 (2015)Global, regional, and nationa…Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 (2014)Global, regional, and nationa…Essential Medicines Are More Available than Other Medicines around the Globe (2014)Essential Medicines Are More …Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis (2008)Medicine prices, availability…The availability and affordability of selected essential medicines for chronicl diseases in six low- and middle-income countries (2007)The availability and affordab…Evaluating Drug Prices, Availability, Affordability, and Price Components: Implications for Access to Drugs in Malaysia (2007)Evaluating Drug Prices, Avail…Catastrophic payments for health care in Asia (2007)Catastrophic payments for hea…Rural‒urban disparities in household catastrophic health expenditure in Bangladesh: a multivariate decomposition analysis (2024)Rural‒urban disparities in ho…World Development Indicators 2005 (2005)THE WORLD MEDICINES SITUATION 2011 (2011)Financial Risk Protection and Universal Health Coverage: Evidence and Measurement Challenges (2014)Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data (2015)Insuring Consumption Against Illness (1997)Catastrophe and impoverishment in paying for health care: with applications to Vietnam 1993–1998 (2003)Household catastrophic health expenditure: a multicountry analysis (2003)Can insurance increase financial risk? (2008)Coping with health-care costs: implications for the measurement of catastrophic expenditures and poverty. (2008)Availability, price and affordability of cardiovascular medicines: A comparison across 36 countries using WHO/HAI data (2010)Differences in the availability of medicines for chronic and acute conditions in the public and private sectors of developing countries (2011)The availability, prices and affordability of essential medicines in Malawi: A cross-sectional study (2019)Access to Cardiovascular Disease and Hypertension Medicines in Developing Countries: An Analysis of Essential Medicine Lists, Price, Availability, and Affordability (2020)Selection and Use of Essential Medicines (2023)XXIV. On the nature of the function expressive of the law of human mortality, and on a new mode of determining the value of life contingencies. In a letter to Francis Baily, Esq. F. R. S. &c (1825)Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 (2012)The State of US Health, 1990-2010 (2013)Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015 (2016)Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016 (2017)Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 (2024)Qualitative Data Analysis: An Expanded Sourcebook (1994)Reforming the health sector in developing countries: the central role of policy analysis (1994)Delivering non-communicable disease services through primary health care in selected south Asian countries: are health systems prepared? (2024)Chapter 7 The human capital model (2000)Spending on Children’s Personal Health Care in the United States, 1996-2013 (2016)What Do We Know About the Association Between Firearm Legislation and Firearm-Related Injuries? (2016)The economic burden of cardiovascular disease and hypertension in low- and middle-income countries: a systematic review (2018)Trade, TRIPS, and pharmaceuticals (2009)Switching from Originator Brand Medicines to Generic Equivalents in Selected Developing Countries: How Much Could Be Saved? (2012)The Economic Costs of Type 2 Diabetes: A Global Systematic Review (2015)Essential medicines for universal health coverage (2016)
this work references cited by second hop

References

  • 2014Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 20137,435 cited
  • 2008Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis926 cited
  • 2015Global, regional, and national age–sex specifi c all-cause andcause-specifi c mortality for 240 causes of death, 1990–2013:a systematic analysis for the Global Burden of DiseaseStudy 2013641 cited
  • 2007Catastrophic payments for health care in Asia623 cited
  • 2007The availability and affordability of selected essential medicines for chronicl diseases in six low- and middle-income countries487 cited
  • 2007Evaluating Drug Prices, Availability, Affordability, and Price Components: Implications for Access to Drugs in Malaysia201 cited
  • 2014Essential Medicines Are More Available than Other Medicines around the Globe126 cited
  • 2017Bangladesh policy on prevention and control of non-communicable diseases: a policy analysis118 cited
  • 2016Bangladesh Health Facility Survey 201442 cited

Cited by

  • 2024Rural‒urban disparities in household catastrophic health expenditure in Bangladesh: a multivariate decomposition analysis26 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work